Lazard Ltd Stock News

Lazard has announced the formation of the Lazard Climate Center to provide insights on the financial effects of climate change and the energy transition on companies and markets. The post Lazard launches Climate Center first appeared on ESG Investing .

At the latest Fund Selector Asia Investment Briefing Hong Kong, FSSA, HSBC GAM and Lazard discussed Japan equities, multi-assets, and convertible bonds. The post Identifying superior investment prospects appeared first on Fund Selector Asia .

Koshinski Asset Management Inc. purchased a new stake in shares of Lazard Ltd (NYSE:LAZ) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 4,220 shares of the asset manager’s stock, valued at approximately $193,000. A number of other hedge funds and other institutional investors have […]

Livingston Group Asset Management CO operating as Southport Capital Management cut its holdings in shares of Lazard Ltd (NYSE:LAZ) by 9.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 21,043 shares of the asset manager’s stock after selling 2,242 shares during the quarter. Livingston Group Asset Management CO operating as Southport Capital Management’s […]

capiton successfully closes sixth private equity fund at EUR504m Submitted 24/11/2021 - 2:09pm German private equity firm capiton has closed its sixth private equity fund capiton VI, with EUR504 million in capital commitments from a diverse investor base. The fund, capiton''s largest to date, will continue its proven sector-focused investment approach of pro-actively sourced primary deals in the German-speaking region. The successful closing of our sixth and yet largest fund represents an important milestone in capitons long-standing history, says Manuel Hertweck, Managing Partner and Board Member of capiton. It is a testament to our strong track record, expertise in our defined sectors and outstanding reputation amongst entrepreneurs who seek a partner to take their business to the next level. On behalf of the capiton management team, I would like to thank our high-quality pool of existing and new investors for their trust and commitment. "With the capital raised for capiton VI, we will continue to follow our successful investment strategy of acquiring majority and minority interests in leading mid-market firms, helping them realize their full potential and creating long-term value with a strong emphasis on ESG. capiton VI was subscribed to by a diverse group of investors entirely virtually including a strong re-up rate of long-standing existing investors as well as new blue-chip institutional investors.

TA Associates makes strategic growth investment in Nactarome Submitted 24/11/2021 - 10:08am TA Associates (TA), a global growth private equity firm, has made a strategic growth investment in Nactarome, a European Group of companies specialising in the development and manufacturing of natural flavours, colours, functional ingredients and clean labels for the food and beverage industry. Upon closing of the transaction, TA will become the majority shareholder, working closing with Nactaromes Management Team, who will retain a minority equity stake. Nactaromes current investor Ambienta, Europes largest sustainability-focused private equity investor, is expected to retain a minority equity stake as well. Financial terms of the transactions were not disclosed. Nactarome represents a unique, strategic asset with a complete product offering across natural flavours, colours and ingredients, addressing a range of end-markets and applications. The Company has solidified its position as a leading independent player in the European natural flavours and ingredients sector, with a diversified customer base of more than 4,200 clients served through 10 specialised production facilities across Europe.

Lazard Ltd (NYSE:LAZ) CAO Scott D. Hoffman sold 25,000 shares of Lazard stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $46.20, for a total value of $1,155,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available []

Lazard Ltd (NYSE:LAZ) CAO Scott D. Hoffman sold 25,000 shares of the businesss stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $46.20, for a total value of $1,155,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is []

Lazard (LAZ) forms a strategic alliance with the newly launched women-owned investment bank and advisory firm, Independence Point Advisors.

Lazard (LAZ) forms a strategic alliance with the newly launched women-owned investment bank and advisory firm, Independence Point Advisors.

NEW YORK--(BUSINESS WIRE)--Lazard Ltd (NYSE: LAZ) and newly launched Independence Point Advisors (IPA) announced today that they have formed a strategic alliance, effective immediately, to provide a suite of bespoke C-suite and board-level services beyond traditional investment banking. Lazard will hold a minority interest in IPA, which was founded by industry veteran Anne Clarke Wolff in 2021. IPAs team of women and diverse leaders with proven track records will provide clients a modern appro

The Blackstone Group (NYSE:BX) and Lazard (NYSE:LAZ) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk. Profitability This table compares The Blackstone Group and Lazards net margins, return on equity and return []

Investment Will Provide BioAgilytix with Additional Resources to Invest in Core Business and Drive Growth DURHAM, N.C. and BRUSSELS, Belgium and LONDON , Nov. 17, 2021 /PRNewswire/ -- BioAgilytix, a leading global contract research organization (CRO), today announced an agreement to be further capitalized by Cinven, a leading international private investment firm focused on building world-class global companies. Cinven will acquire a majority stake in BioAgilytix while current majority investor Cobepa, S.A., a Brussels -based private investment firm, will remain a significant minority investor in the Company. Cobepa and GHO Capital, a leading specialist investor in global healthcare, acquired BioAgilytix in November of 2018 and have built the company into a recognized global leader in the contract research organization market with a focus on large molecule bioanalytical testing. The investment by Cinven will provide BioAgilytix with increased funding and resources to meet the growing demand for its high-quality bioanalytical services, driven by its strong scientific reputation and leading expertise in supporting the development and commercialization of novel therapeutics. "Our focus on providing customers with industry leading scientific expertise coupled with superior service across the pharmaceutical development pathway has been our formula for success," said Jim Datin , President and CEO of BioAgilytix. "As we move into our next chapter of our evolution, Cinven will provide the additional resources that will empower us to expand not only our geographical reach but will also enable us to invest further in our talent and facilities around the globe to meet the ever-growing needs of our customers." Peter Connolly , Managing Director and Head of North America of Cobepa said, "We are excited to continue working with Jim and the entire BioAgilytix management team and are thrilled to welcome Cinven as a new investor in the Company.

Related Stocks: WBA , KMB , LEMB , BAC , UNP , FEMB , LAZ , EMXC , PENN , GE , BSJN , RYH , BABA , COIN , WYNN , SLB , JMIA , ASHR ,